Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$883M |
| 2 |
Microsoft
MSFT
|
+$870M |
| 3 |
Amazon
AMZN
|
+$600M |
| 4 |
Meta Platforms (Facebook)
META
|
+$343M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$52.4M |
| 2 |
ZAYO
Zayo Group Holdings, Inc.
ZAYO
|
+$32.8M |
| 3 |
LPT
Liberty Property Trust
LPT
|
+$29.6M |
| 4 |
MDCO
Medicines Co
MDCO
|
+$12.9M |
| 5 |
INXN
Interxion Holding N.V.
INXN
|
+$12.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.52% |
| 2 | Healthcare | 15.94% |
| 3 | Consumer Discretionary | 11.41% |
| 4 | Communication Services | 10.51% |
| 5 | Consumer Staples | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Bloomin' Brands
BLMN
$963M
| $1.14M | ﹤0.01% |
160,000
+2,100
| +1% | +$36.6K |
|
1752
Anterix
ATEX
$1.8B
| $1.14M | ﹤0.01% |
24,950
+500
| +2% | +$22.6K |
|
1753
Akebia Therapeutics
AKBA
$250M
| $1.14M | ﹤0.01% |
149,985
+2,100
| +1% | +$16.3K |
|
1754
OneSpan
OSPN
$613M
| $1.13M | ﹤0.01% |
62,400
+700
| +1% | +$11.9K |
|
|
IMGN
1755
DELISTED
Immunogen Inc
IMGN
| $1.13M | ﹤0.01% |
331,700
+44,800
| +16% | +$196K |
|
|
SILK
1756
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $1.13M | ﹤0.01% |
35,900
+700
| +2% | +$28K |
|
1757
GrafTech
EAF
$202M
| $1.13M | ﹤0.01% |
13,910
| – | – |
|
1758
Levi Strauss
LEVI
$8.61B
| $1.13M | ﹤0.01% |
90,700
+1,200
| +1% | +$21.2K |
|
1759
Andersons Inc
ANDE
$2.23B
| $1.13M | ﹤0.01% |
60,050
+800
| +1% | +$16.9K |
|
1760
PetMed Express
PETS
$42.7M
| $1.13M | ﹤0.01% |
39,100
+500
| +1% | +$13.1K |
|
|
VBTX
1761
DELISTED
Veritex Holdings
VBTX
| $1.13M | ﹤0.01% |
80,517
-900
| -1% | -$21.7K |
|
|
ADVM
1762
DELISTED
Adverum Biotechnologies
ADVM
| $1.12M | ﹤0.01% |
11,500
+1,020
| +10% | +$119K |
|
1763
1st Source
SRCE
$2.14B
| $1.12M | ﹤0.01% |
34,589
+300
| +0.9% | +$13K |
|
1764
The Greenbrier Companies
GBX
$1.42B
| $1.12M | ﹤0.01% |
63,200
+1,100
| +2% | +$26.1K |
|
1765
Goosehead Insurance
GSHD
$2.34B
| $1.12M | ﹤0.01% |
25,100
+400
| +2% | +$19.8K |
|
1766
Upland Software
UPLD
$16.8M
| $1.12M | ﹤0.01% |
4,160
+60
| +1% | +$21.7K |
|
|
ADAM
1767
Adamas Trust
ADAM
$913M
| $1.11M | ﹤0.01% |
179,855
+55,975
| +45% | +$1.18M |
|
1768
OFG Bancorp
OFG
$2.26B
| $1.11M | ﹤0.01% |
99,600
+1,400
| +1% | +$25.1K |
|
1769
Universal Insurance Holdings
UVE
$1.19B
| $1.11M | ﹤0.01% |
62,100
| – | – |
|
1770
Washington Trust Bancorp
WASH
$760M
| $1.11M | ﹤0.01% |
30,300
+500
| +2% | +$22.6K |
|
|
OSB
1771
DELISTED
Norbord Inc.
OSB
| $1.11M | ﹤0.01% |
95,328
+1,300
| +1% | +$32.8K |
|
|
BMTC
1772
DELISTED
Bryn Mawr Bank Corp
BMTC
| $1.11M | ﹤0.01% |
39,000
+400
| +1% | +$14K |
|
1773
Abercrombie & Fitch
ANF
$4.94B
| $1.11M | ﹤0.01% |
121,700
-4,100
| -3% | -$59.4K |
|
1774
Gorman-Rupp
GRC
$2.15B
| $1.11M | ﹤0.01% |
35,447
+500
| +1% | +$16.9K |
|
|
RWT
1775
Redwood Trust
RWT
$597M
| $1.11M | ﹤0.01% |
218,600
+7,600
| +4% | +$113K |
|
Similar funds
Swiss National Bank's Q1 2020 Portfolio in Review
As of Q1 2020, Swiss National Bank held 2,510 positions worth $94.2B, down 3.4% from $97.5B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Swiss National Bank deployed $18.4B of net new capital in Q1 2020, opening 4 new positions and adding to 1,998 existing holdings. Its largest new stake was Luckin Coffee Inc. American Depositary Shares: 165,417 shares worth $4.5M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was C.H. Robinson, an estimated $5.64M trimmed.
- Swiss National Bank's largest Q1 2020 buy was Luckin Coffee Inc. American Depositary Shares: 165,417 shares worth $4.5M.
- Swiss National Bank added most to Apple in Q1 2020, an estimated $883M increase.
- Swiss National Bank's biggest Q1 2020 reduction was C.H. Robinson, cutting an estimated $5.64M.
- Swiss National Bank fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $52.4M.
- Swiss National Bank's ten largest holdings make up 22% of its $94.2B portfolio in Q1 2020.
- Swiss National Bank opened 4 new positions and closed 30 in Q1 2020.
- Swiss National Bank's portfolio value fell 3.4% quarter-over-quarter to $94.2B.
Based on Swiss National Bank's 13F filing for Q1 2020, filed 8 May 2020.